First human test of new oral weight loss pill begins
Disease control
Completed
This early-stage study tested the safety of a new oral medication called ecnoglutide in 87 healthy adults. The medication is being developed to help manage type 2 diabetes and obesity. Researchers gave participants increasing doses to check for side effects and see how the body p…
Phase: PHASE1 • Sponsor: Sciwind Biosciences APAC CO Pty. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC